The reported study revealed that YY1 inhibits the EMT process in bladder cancer cells by reducing expression levels, regulating the TGF‐β pathway, and maybe a potential therapeutic target for future bladder cancer.21 Here, TGFB1 is linked to urinary bladder carcinoma.